DE69527521D1 - Behandlung von biologischen materialen vor der fixierung - Google Patents

Behandlung von biologischen materialen vor der fixierung

Info

Publication number
DE69527521D1
DE69527521D1 DE69527521T DE69527521T DE69527521D1 DE 69527521 D1 DE69527521 D1 DE 69527521D1 DE 69527521 T DE69527521 T DE 69527521T DE 69527521 T DE69527521 T DE 69527521T DE 69527521 D1 DE69527521 D1 DE 69527521D1
Authority
DE
Germany
Prior art keywords
biological material
heart valve
treatment
biological materials
before fixing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69527521T
Other languages
English (en)
Other versions
DE69527521T2 (de
Inventor
Norman Jaffe
B Hancock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HANROCK JAFFE LAB IRVINE
Original Assignee
HANROCK JAFFE LAB IRVINE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HANROCK JAFFE LAB IRVINE filed Critical HANROCK JAFFE LAB IRVINE
Application granted granted Critical
Publication of DE69527521D1 publication Critical patent/DE69527521D1/de
Publication of DE69527521T2 publication Critical patent/DE69527521T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
    • A61L27/3645—Connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3691—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/507—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials for artificial blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/20—Materials or treatment for tissue regeneration for reconstruction of the heart, e.g. heart valves
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S623/00—Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
    • Y10S623/901—Method of manufacturing prosthetic device
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S623/00—Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
    • Y10S623/915—Method or apparatus for preparing biological material
DE69527521T 1994-04-18 1995-03-21 Behandlung von biologischen materialen vor der fixierung Expired - Fee Related DE69527521T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/229,452 US5595571A (en) 1994-04-18 1994-04-18 Biological material pre-fixation treatment
PCT/US1995/003569 WO1995028183A1 (en) 1994-04-18 1995-03-21 Biological material pre-fixation treatment

Publications (2)

Publication Number Publication Date
DE69527521D1 true DE69527521D1 (de) 2002-08-29
DE69527521T2 DE69527521T2 (de) 2003-05-08

Family

ID=22861309

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69527521T Expired - Fee Related DE69527521T2 (de) 1994-04-18 1995-03-21 Behandlung von biologischen materialen vor der fixierung

Country Status (9)

Country Link
US (4) US5595571A (de)
EP (1) EP0756498B1 (de)
AT (1) ATE220929T1 (de)
AU (1) AU3513395A (de)
DE (1) DE69527521T2 (de)
DK (1) DK0756498T3 (de)
ES (1) ES2180653T3 (de)
PT (1) PT756498E (de)
WO (1) WO1995028183A1 (de)

Families Citing this family (141)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5595571A (en) * 1994-04-18 1997-01-21 Hancock Jaffe Laboratories Biological material pre-fixation treatment
USRE40570E1 (en) 1994-07-29 2008-11-11 Edwards Lifesciences Corporation Apparatuses and methods for treating biological tissue to mitigate calcification
US5931969A (en) 1994-07-29 1999-08-03 Baxter International Inc. Methods and apparatuses for treating biological tissue to mitigate calcification
EP0804255B1 (de) 1994-07-29 2001-10-04 Edwards Lifesciences Corporation Verfahren zur behandlung von implantierbaren biologischen geweben zur verringerung von verkalkung
US6121041A (en) * 1996-07-31 2000-09-19 St. Jude Medical, Inc. Use of microorganisms for decellularizing bioprosthetic tissue
AU746318B2 (en) * 1997-04-11 2002-04-18 Cryolife, Inc. Tissue decellularization
US5993844A (en) * 1997-05-08 1999-11-30 Organogenesis, Inc. Chemical treatment, without detergents or enzymes, of tissue to form an acellular, collagenous matrix
US5862806A (en) * 1997-10-30 1999-01-26 Mitroflow International, Inc. Borohydride reduction of biological tissues
US6371992B1 (en) * 1997-12-19 2002-04-16 The Regents Of The University Of California Acellular matrix grafts: preparation and use
EP1049425B1 (de) * 1997-12-29 2009-11-25 Cleveland Clinic Foundation The System zur minimalinvasiven einführung einer herzklappen- bioprothese
US6530952B2 (en) * 1997-12-29 2003-03-11 The Cleveland Clinic Foundation Bioprosthetic cardiovascular valve system
US6734018B2 (en) * 1999-06-07 2004-05-11 Lifenet Process for decellularizing soft-tissue engineered medical implants, and decellularized soft-tissue medical implants produced
US7063726B2 (en) * 1998-06-30 2006-06-20 Lifenet Plasticized bone grafts and methods of making and using same
US6743574B1 (en) 2000-09-12 2004-06-01 Lifenet Process for devitalizing soft-tissue engineered medical implants, and devitalized soft-tissue medical implants produced
US8563232B2 (en) 2000-09-12 2013-10-22 Lifenet Health Process for devitalizing soft-tissue engineered medical implants, and devitalized soft-tissue medical implants produced
US6293970B1 (en) * 1998-06-30 2001-09-25 Lifenet Plasticized bone and soft tissue grafts and methods of making and using same
US6254564B1 (en) 1998-09-10 2001-07-03 Percardia, Inc. Left ventricular conduit with blood vessel graft
US6214054B1 (en) * 1998-09-21 2001-04-10 Edwards Lifesciences Corporation Method for fixation of biological tissues having mitigated propensity for post-implantation calcification and thrombosis and bioprosthetic devices prepared thereby
US6334873B1 (en) * 1998-09-28 2002-01-01 Autogenics Heart valve having tissue retention with anchors and an outer sheath
JP4663120B2 (ja) 1998-09-30 2011-03-30 メドトロニック，インコーポレイテッド 移植で使用される組織の無機質化を減少させる方法
US20050033399A1 (en) * 1998-12-03 2005-02-10 Jacob Richter Hybrid stent
US20060178727A1 (en) * 1998-12-03 2006-08-10 Jacob Richter Hybrid amorphous metal alloy stent
US20070219642A1 (en) * 1998-12-03 2007-09-20 Jacob Richter Hybrid stent having a fiber or wire backbone
US20060122691A1 (en) * 1998-12-03 2006-06-08 Jacob Richter Hybrid stent
US20040267349A1 (en) * 2003-06-27 2004-12-30 Kobi Richter Amorphous metal alloy medical devices
US8382821B2 (en) 1998-12-03 2013-02-26 Medinol Ltd. Helical hybrid stent
US6524339B1 (en) * 1999-01-27 2003-02-25 David H. Adams Cryopreserved homografts and other stentless bioprosthetic heart valves having natural tissue sewing rings
US6903244B1 (en) 1999-02-26 2005-06-07 University Of Utah Research Foundation Mice which are +/− or −/− for the elastin gene as models for vascular disease
AU4054800A (en) * 1999-04-02 2000-10-23 Cryolife, Inc. Unstented heart valve bioprostheses and methods of making the same
US6440164B1 (en) 1999-10-21 2002-08-27 Scimed Life Systems, Inc. Implantable prosthetic valve
US6866686B2 (en) * 2000-01-28 2005-03-15 Cryolife, Inc. Tissue graft
CA2840468C (en) * 2000-01-31 2016-07-26 Cook Biotech Incorporated Stent valves and uses of same
DE10010073B4 (de) * 2000-02-28 2005-12-22 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Verankerung für implantierbare Herzklappenprothesen
DE10010074B4 (de) 2000-02-28 2005-04-14 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Vorrichtung zur Befestigung und Verankerung von Herzklappenprothesen
US7141062B1 (en) * 2000-03-01 2006-11-28 Medinol, Ltd. Longitudinally flexible stent
US6723119B2 (en) 2000-03-01 2004-04-20 Medinol Ltd. Longitudinally flexible stent
US7828835B2 (en) * 2000-03-01 2010-11-09 Medinol Ltd. Longitudinally flexible stent
US8920487B1 (en) 2000-03-01 2014-12-30 Medinol Ltd. Longitudinally flexible stent
US8202312B2 (en) * 2000-03-01 2012-06-19 Medinol Ltd. Longitudinally flexible stent
US8496699B2 (en) * 2000-03-01 2013-07-30 Medinol Ltd. Longitudinally flexible stent
US7621947B2 (en) 2000-03-01 2009-11-24 Medinol, Ltd. Longitudinally flexible stent
US7758627B2 (en) * 2000-03-01 2010-07-20 Medinol, Ltd. Longitudinally flexible stent
SG86458A1 (en) 2000-03-01 2002-02-19 Medinol Ltd Longitudinally flexible stent
US6736838B1 (en) 2000-03-22 2004-05-18 Zuli Holdings Ltd. Method and apparatus for covering a stent
AU2001284968B2 (en) * 2000-08-16 2006-12-21 Duke University Decellularized tissue engineered constructs and tissues
AUPR217300A0 (en) * 2000-12-20 2001-01-25 Ketharanathan, Vettivetpillai Method of creating biological and biosynthetic material for implantation
US7078163B2 (en) * 2001-03-30 2006-07-18 Medtronic, Inc. Process for reducing mineralization of tissue used in transplantation
FR2828263B1 (fr) * 2001-08-03 2007-05-11 Philipp Bonhoeffer Dispositif d'implantation d'un implant et procede d'implantation du dispositif
EP1317934A1 (de) * 2001-11-08 2003-06-11 Artiss GmbH Verfahren zur Herstellung einer azellularisierten Gewebematrix und damit erhältliche Gewebematrix
US6878168B2 (en) 2002-01-03 2005-04-12 Edwards Lifesciences Corporation Treatment of bioprosthetic tissues to mitigate post implantation calcification
WO2003082203A2 (en) * 2002-03-27 2003-10-09 University Of Utah Research Foundation Elastin prevents occlusion of body vessels by vascular smooth muscle cells
US7270675B2 (en) * 2002-05-10 2007-09-18 Cordis Corporation Method of forming a tubular membrane on a structural frame
US7351256B2 (en) * 2002-05-10 2008-04-01 Cordis Corporation Frame based unidirectional flow prosthetic implant
US7485141B2 (en) * 2002-05-10 2009-02-03 Cordis Corporation Method of placing a tubular membrane on a structural frame
WO2003094795A1 (en) 2002-05-10 2003-11-20 Cordis Corporation Method of making a medical device having a thin wall tubular membrane over a structural frame
EP1649879A3 (de) * 2002-06-28 2006-05-03 Cardio, Inc. Dezellularisiertes Gewebe
CH696185A5 (fr) * 2003-03-21 2007-02-15 Afksendiyos Kalangos Dispositif de renfort intraparietal pour prothèse biologique et prothèse biologique renforcée.
US7374488B2 (en) * 2003-04-17 2008-05-20 Atronic Systems G.M.B.H. Player insert for a gaming machine, a gaming system and a method of operating a gaming system
US9155639B2 (en) * 2009-04-22 2015-10-13 Medinol Ltd. Helical hybrid stent
US9039755B2 (en) 2003-06-27 2015-05-26 Medinol Ltd. Helical hybrid stent
US7955788B2 (en) * 2003-10-30 2011-06-07 Medtronic, Inc. Bioprosthetic tissue preparation with synthetic hydrogels
US7070616B2 (en) * 2003-10-31 2006-07-04 Cordis Corporation Implantable valvular prosthesis
US7347869B2 (en) 2003-10-31 2008-03-25 Cordis Corporation Implantable valvular prosthesis
US20050266390A1 (en) * 2004-06-01 2005-12-01 Yuichiro Ueda Processes for removing cells and cell debris from tissue and tissue constructs used in transplantation and tissue reconstruction
US7763064B2 (en) 2004-06-08 2010-07-27 Medinol, Ltd. Stent having struts with reverse direction curvature
US7758640B2 (en) * 2004-12-16 2010-07-20 Valvexchange Inc. Cardiovascular valve assembly
DE102005003632A1 (de) 2005-01-20 2006-08-17 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Katheter für die transvaskuläre Implantation von Herzklappenprothesen
MX2007010600A (es) * 2005-03-01 2007-10-10 Raymond Andrieu Dispersion de refuerzo intraparietal para protesis cardiaca biologica y protesis biologica reforzada de valvula cardiaca.
US7579381B2 (en) * 2005-03-25 2009-08-25 Edwards Lifesciences Corporation Treatment of bioprosthetic tissues to mitigate post implantation calcification
MX2007013725A (es) * 2005-05-05 2008-04-09 Sensient Flavors Inc Produccion de beta-glucanos y mananos.
DE102005051849B4 (de) 2005-10-28 2010-01-21 JenaValve Technology Inc., Wilmington Vorrichtung zur Implantation und Befestigung von Herzklappenprothesen
DE102005052628B4 (de) * 2005-11-04 2014-06-05 Jenavalve Technology Inc. Selbstexpandierendes, flexibles Drahtgeflecht mit integrierter Klappenprothese für den transvaskulären Herzklappenersatz und ein System mit einer solchen Vorrichtung und einem Einführkatheter
US20070213813A1 (en) 2005-12-22 2007-09-13 Symetis Sa Stent-valves for valve replacement and associated methods and systems for surgery
US8105634B2 (en) * 2006-08-15 2012-01-31 Anthrogenesis Corporation Umbilical cord biomaterial for medical use
WO2008073582A2 (en) 2006-10-27 2008-06-19 Edwards Lifesciences Corporation Biological tissue for surgical implantation
EP2114318A4 (de) * 2007-01-18 2015-01-21 Valvexchange Inc Werkzeuge zur entfernung und installation austauschbarer kardiovaskulärer klappen
WO2008094691A2 (en) * 2007-02-01 2008-08-07 Cook Incorporated Closure device and method for occluding a bodily passageway
US8617205B2 (en) 2007-02-01 2013-12-31 Cook Medical Technologies Llc Closure device
WO2008094706A2 (en) * 2007-02-01 2008-08-07 Cook Incorporated Closure device and method of closing a bodily opening
US20080260794A1 (en) * 2007-02-12 2008-10-23 Lauritzen Nels J Collagen products and methods for producing collagen products
US9056151B2 (en) * 2007-02-12 2015-06-16 Warsaw Orthopedic, Inc. Methods for collagen processing and products using processed collagen
US9138315B2 (en) * 2007-04-13 2015-09-22 Jenavalve Technology Gmbh Medical device for treating a heart valve insufficiency or stenosis
US7896915B2 (en) 2007-04-13 2011-03-01 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
US9295551B2 (en) * 2007-04-13 2016-03-29 Jenavalve Technology Gmbh Methods of implanting an endoprosthesis
US8403979B2 (en) 2007-05-17 2013-03-26 Cook Medical Technologies Llc Monocuspid prosthetic valve having a partial sinus
US9101691B2 (en) * 2007-06-11 2015-08-11 Edwards Lifesciences Corporation Methods for pre-stressing and capping bioprosthetic tissue
US7815677B2 (en) 2007-07-09 2010-10-19 Leman Cardiovascular Sa Reinforcement device for a biological valve and reinforced biological valve
US20090024224A1 (en) 2007-07-16 2009-01-22 Chen Silvia S Implantation of cartilage
EP2182860A4 (de) 2007-08-21 2013-07-24 Valvexchange Inc Verfahren und vorrichtung zur entfernung von herzklappenprothesen
US8025495B2 (en) * 2007-08-27 2011-09-27 Cook Medical Technologies Llc Apparatus and method for making a spider occlusion device
US20090062838A1 (en) * 2007-08-27 2009-03-05 Cook Incorporated Spider device with occlusive barrier
US8734483B2 (en) * 2007-08-27 2014-05-27 Cook Medical Technologies Llc Spider PFO closure device
US8308752B2 (en) * 2007-08-27 2012-11-13 Cook Medical Technologies Llc Barrel occlusion device
US20090105810A1 (en) 2007-10-17 2009-04-23 Hancock Jaffe Laboratories Biological valve for venous valve insufficiency
US20090105813A1 (en) 2007-10-17 2009-04-23 Sean Chambers Implantable valve device
US8057532B2 (en) * 2007-11-28 2011-11-15 Cook Medical Technologies Llc Implantable frame and valve design
US8357387B2 (en) 2007-12-21 2013-01-22 Edwards Lifesciences Corporation Capping bioprosthetic tissue to reduce calcification
US8211165B1 (en) 2008-01-08 2012-07-03 Cook Medical Technologies Llc Implantable device for placement in a vessel having a variable size
US9044318B2 (en) 2008-02-26 2015-06-02 Jenavalve Technology Gmbh Stent for the positioning and anchoring of a valvular prosthesis
ES2903231T3 (es) 2008-02-26 2022-03-31 Jenavalve Tech Inc Stent para el posicionamiento y anclaje de una prótesis valvular en un sitio de implantación en el corazón de un paciente
US8317858B2 (en) 2008-02-26 2012-11-27 Jenavalve Technology, Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US8398704B2 (en) 2008-02-26 2013-03-19 Jenavalve Technology, Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US9168130B2 (en) 2008-02-26 2015-10-27 Jenavalve Technology Gmbh Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US8465540B2 (en) 2008-02-26 2013-06-18 Jenavalve Technology, Inc. Stent for the positioning and anchoring of a valvular prosthesis
WO2009129481A1 (en) * 2008-04-18 2009-10-22 Cook Incorporated Branched vessel prosthesis
CA2736817A1 (en) 2008-09-12 2010-03-18 Valvexchange Inc. Valve assembly with exchangeable valve member and a tool set for exchanging the valve member
US8333803B2 (en) 2008-11-21 2012-12-18 Lifecell Corporation Reinforced biologic material
US20100261662A1 (en) * 2009-04-09 2010-10-14 Endologix, Inc. Utilization of mural thrombus for local drug delivery into vascular tissue
US8468667B2 (en) * 2009-05-15 2013-06-25 Jenavalve Technology, Inc. Device for compressing a stent
WO2011038023A1 (en) * 2009-09-22 2011-03-31 Colorado State University Research Foundation Methods for processing biological tissues
EP2674174B1 (de) 2010-03-23 2019-10-16 Edwards Lifesciences Corporation Verfahren zur bearbeitung eines scheibenförmigen bioprothese-gewebes
CA2794173A1 (en) 2010-03-24 2011-09-29 Christopher J. Criscuolo Combination three-dimensional surgical implant
MX2012011354A (es) 2010-03-30 2012-11-30 Histocell Sl Nuevo biomaterial procedente de gelatina de wharton de cordon umbilical.
US8790699B2 (en) 2010-04-23 2014-07-29 Warsaw Orthpedic, Inc. Foam-formed collagen strand
US8460691B2 (en) 2010-04-23 2013-06-11 Warsaw Orthopedic, Inc. Fenestrated wound repair scaffold
US11278406B2 (en) 2010-05-20 2022-03-22 Jenavalve Technology, Inc. Catheter system for introducing an expandable heart valve stent into the body of a patient, insertion system with a catheter system and medical device for treatment of a heart valve defect
US10856978B2 (en) 2010-05-20 2020-12-08 Jenavalve Technology, Inc. Catheter system
CN103002833B (zh) 2010-05-25 2016-05-11 耶拿阀门科技公司 人工心脏瓣及包括人工心脏瓣和支架的经导管输送的内假体
US8906601B2 (en) 2010-06-17 2014-12-09 Edwardss Lifesciences Corporation Methods for stabilizing a bioprosthetic tissue by chemical modification of antigenic carbohydrates
KR101258213B1 (ko) 2010-07-07 2013-04-25 신경민 심낭을 이용한 인공심장판막도관 및 제조방법
EP2627265B8 (de) 2010-10-15 2019-02-20 Cook Medical Technologies LLC Okklusionsvorrichtung zum blockieren des flüssigkeitsflusses durch körperdurchgänge
US9351829B2 (en) 2010-11-17 2016-05-31 Edwards Lifesciences Corporation Double cross-linkage process to enhance post-implantation bioprosthetic tissue durability
US9358107B2 (en) 2011-06-30 2016-06-07 Edwards Lifesciences Corporation Systems, dies, and methods for processing pericardial tissue
JP6005168B2 (ja) 2011-10-21 2016-10-12 イエナバルブ テクノロジー インク 患者の身体への拡張型心臓弁ステント導入用カテーテルシステム、カテーテルシステムを備えた挿入システムおよび心臓弁欠陥治療用医療機器
CN102350008A (zh) 2011-10-25 2012-02-15 微创医疗器械(上海)有限公司 一种处理动物源性胶原纤维材料的方法
EP3281608B1 (de) 2012-02-10 2020-09-16 CVDevices, LLC Produit medical contenant une armature et plèvre viscérale
WO2013169366A1 (en) 2012-05-11 2013-11-14 Rti Biologics, Inc. Xenograft soft tissue implants and methods of making and using
JP6227632B2 (ja) 2012-05-16 2017-11-08 イェーナヴァルヴ テクノロジー ゲゼルシャフト ミット ベシュレンクテル ハフツング 拡張可能心臓代用弁を導入するためのカテーテル送達システムおよび心臓弁欠陥の治療のための医療デバイス
US10238771B2 (en) 2012-11-08 2019-03-26 Edwards Lifesciences Corporation Methods for treating bioprosthetic tissue using a nucleophile/electrophile in a catalytic system
AU2014214700B2 (en) 2013-02-11 2018-01-18 Cook Medical Technologies Llc Expandable support frame and medical device
JP6563394B2 (ja) 2013-08-30 2019-08-21 イェーナヴァルヴ テクノロジー インコーポレイテッド 人工弁のための径方向に折り畳み自在のフレーム及び当該フレームを製造するための方法
US9615922B2 (en) 2013-09-30 2017-04-11 Edwards Lifesciences Corporation Method and apparatus for preparing a contoured biological tissue
US10959839B2 (en) 2013-10-08 2021-03-30 Edwards Lifesciences Corporation Method for directing cellular migration patterns on a biological tissue
US10022218B2 (en) * 2014-02-14 2018-07-17 Cook Medical Technologies Llc Tricuspid regurgitation model and methods of evaluating intraluminal medical devices
US9238090B1 (en) 2014-12-24 2016-01-19 Fettech, Llc Tissue-based compositions
WO2016154452A2 (en) 2015-03-24 2016-09-29 Osiris Therapeutics, Inc. Compositions comprising meniscal tissues and uses thereof
WO2016177562A1 (en) 2015-05-01 2016-11-10 Jenavalve Technology, Inc. Device and method with reduced pacemaker rate in heart valve replacement
WO2017195125A1 (en) 2016-05-13 2017-11-16 Jenavalve Technology, Inc. Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system
US11197754B2 (en) 2017-01-27 2021-12-14 Jenavalve Technology, Inc. Heart valve mimicry
CA3116158A1 (en) 2018-11-01 2020-05-07 Edwards Lifesciences Corporation Transcatheter pulmonic regenerative valve
KR102411248B1 (ko) 2019-06-21 2022-06-21 주식회사 에스앤지바이오텍 무세포화 처리방법

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4050893A (en) * 1974-07-22 1977-09-27 Hancock Laboratories, Inc. Arrangement for preparing natural tissue for implantation
DE2453363B2 (de) * 1974-11-11 1976-08-26 Solco Basel AG, Birsfelden (Schweiz) Verfahren zur herstellung heterologer arterientransplantate
IL47062A (en) * 1975-04-10 1979-07-25 Yeda Res & Dev Process for diminishing antigenicity of tissues to be usedas transplants by treatment with glutaraldehyde
DK139607B (da) * 1976-04-12 1979-03-19 Biocoating Aps Biologisk protese samt fremgangsmåde til fremstilling heraf.
US4239492A (en) * 1979-06-14 1980-12-16 Beisang Arthur A Method of preparing vascular grafts of human and other umbilical cord origins for tissue ingrowth
EP0037381B1 (de) * 1980-03-31 1984-10-17 Solco Basel AG Verfahren zur Herstellung neuer Organtransplantate
US4378224A (en) * 1980-09-19 1983-03-29 Nimni Marcel E Coating for bioprosthetic device and method of making same
US4323358A (en) * 1981-04-30 1982-04-06 Vascor, Inc. Method for inhibiting mineralization of natural tissue during implantation
FR2523810B1 (fr) * 1982-03-23 1988-11-25 Carpentier Alain Tissu biologique greffable et procede pour sa preparation
JPS58180162A (ja) * 1982-04-19 1983-10-21 株式会社高研 抗血栓性医用材料
US4405327A (en) * 1982-08-25 1983-09-20 Extracorporeal Medical Specialties, Inc. Method for inhibiting mineralization of natural tissue during implantation
US4402697A (en) * 1982-08-25 1983-09-06 Extracorporeal Medical Specialties, Inc. Method for inhibiting mineralization of natural tissue during implantation
US5215541A (en) * 1982-11-12 1993-06-01 Baxter International Inc. Surfactant treatment of implantable biological tissue to inhibit calcification
EP0124596A4 (de) * 1982-11-12 1985-06-26 American Hospital Supply Corp Chemische sterilisation einpflanzbarer biologischer gewebe.
US4885005A (en) * 1982-11-12 1989-12-05 Baxter International Inc. Surfactant treatment of implantable biological tissue to inhibit calcification
US4801299A (en) * 1983-06-10 1989-01-31 University Patents, Inc. Body implants of extracellular matrix and means and methods of making and using such implants
CA1220001A (en) * 1983-07-12 1987-04-07 Robert P. Totten Tissue valve
GB8413319D0 (en) * 1984-05-24 1984-06-27 Oliver Roy Frederick Biological material
US4553974A (en) * 1984-08-14 1985-11-19 Mayo Foundation Treatment of collagenous tissue with glutaraldehyde and aminodiphosphonate calcification inhibitor
US4729139A (en) * 1985-11-05 1988-03-08 Baxter Travenol Selective incorporation of a polymer into implantable biological tissue to inhibit calcification
US4770665A (en) * 1985-11-05 1988-09-13 American Hospital Supply Corporation Elastomeric polymer incorporation into implantable biological tissue to inhibit calcification
DE3541478A1 (de) * 1985-11-23 1987-05-27 Beiersdorf Ag Herzklappenprothese und verfahren zu deren herstellung
GB8618374D0 (en) * 1986-07-28 1986-09-03 Hsc Res Dev Corp Biological vascular prostheses
US4786287A (en) * 1986-10-10 1988-11-22 Baxter Travenol Laboratories Process for decreasing residual aldehyde levels in implantable bioprosthetic tissue
US4798611A (en) * 1986-10-14 1989-01-17 Hancock Jaffe Laboratories Enhancement of xenogeneic tissue
US4800603A (en) * 1987-01-30 1989-01-31 Jaffe Norman R Tissue fixation with vapor
US4838888A (en) * 1987-04-17 1989-06-13 Baxter Travenol Laboratories, Inc. Calcification mitigation of implantable bioprostheses
US4976733A (en) * 1988-02-03 1990-12-11 Biomedical Design, Inc. Prevention of prosthesis calcification
US5094661A (en) * 1988-04-01 1992-03-10 The University Of Michigan Calcification-resistant materials and methods of making same through use of trivalent aluminum
US5002566A (en) * 1989-02-17 1991-03-26 Baxter International Inc. Calcification mitigation of bioprosthetic implants
US5145771A (en) * 1990-04-12 1992-09-08 The University Of North Carolina At Chapel Hill Rinse solution for organs and tissues
US5336616A (en) * 1990-09-12 1994-08-09 Lifecell Corporation Method for processing and preserving collagen-based tissues for transplantation
CA2089336C (en) * 1990-09-12 2000-04-25 Stephen A. Livesey Method for processing and preserving collagen-based tissues for transplantation
US5104405A (en) * 1991-02-21 1992-04-14 The University Of Southern California Process for improving the biostability of tissue implant devices and bioprosthetic implants so produced
US5192312A (en) * 1991-03-05 1993-03-09 Colorado State University Research Foundation Treated tissue for implantation and methods of treatment and use
US5595571A (en) * 1994-04-18 1997-01-21 Hancock Jaffe Laboratories Biological material pre-fixation treatment

Also Published As

Publication number Publication date
US5595571A (en) 1997-01-21
US5843181A (en) 1998-12-01
US5843180A (en) 1998-12-01
WO1995028183A1 (en) 1995-10-26
AU3513395A (en) 1995-11-10
US5720777A (en) 1998-02-24
DE69527521T2 (de) 2003-05-08
ES2180653T3 (es) 2003-02-16
EP0756498A1 (de) 1997-02-05
PT756498E (pt) 2002-12-31
DK0756498T3 (da) 2002-11-11
ATE220929T1 (de) 2002-08-15
EP0756498B1 (de) 2002-07-24

Similar Documents

Publication Publication Date Title
DE69527521T2 (de) Behandlung von biologischen materialen vor der fixierung
ATE243537T1 (de) Vernetzung von bioprothesematerial zur kalzifikationsverminderung nach implantation
DE68918285T2 (de) Methode für behandlung von transplantaten vor transplantationen.
DE69525151D1 (de) Methoden zur krankheitsbehandlung unter verwendung von sertoli-zellen und allotransplantat oder xenotransplantat
DE3855220D1 (de) Methode zur beseitigung von infektionserregern in geweben
CA2196165A1 (en) Methods for treating implantable biological tissues to mitigate the calcification thereof and bioprosthetic articles treated by such methods
DE122007000080I2 (de) Verwendung von c-22 bis c-26-aliphatischen alkoholen zur behandlung entzündlicher und viraler hauterkrankungen.
DK0603920T3 (da) Fremgangsmåde til behandling af knoglevæv og tilsvarende implanterbare biologiske materialer
DE60045034D1 (de) Überstände von mesenchymstammzellen zur vorbeugung und behandlung von immunantworten in transplantationen
DE69028535D1 (de) Herstellung des vaskulären endothelialen zellwachstumsfaktors
SE8403239D0 (sv) Modification of polyglycolic structural elements to achieve variable in-vivo physical properties
DE3785602D1 (de) Verwendung von a-, b- und c-prostaglandinen und deren derivaten zur behandlung von augen-hypertension und glaukom.
DE58907855D1 (de) Verfahren zur herstellung von rinder-pericard-materialien und ihre verwendung.
YU183690A (sh) Postupak za nitrokarbonizaciju konstrukcionih elemenata od čelika
CA2001448A1 (en) Method for sanitizing and improving the hatchability of hatchery eggs
ATE89728T1 (de) Verwendung von dihydroergotamin und seinen salzen zur lokalen behandlung trophischer stoerungen.
DE58902451D1 (de) (s)-emopamil zur anwendung bei der behandlung von migraene.
DE69026511D1 (de) Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis
ATE56149T1 (de) Verfahren zum pasteurisieren von fibronectin.
DE3850655D1 (de) Verfahren zur Behandlung von Implantatmaterial und Implantat.
CA2188135A1 (en) Biological material pre-fixation treatment
ATE178336T1 (de) Verwendung einer therapeutischen zusammensetzung zur behandlung von bronchitis
RU1836940C (ru) Способ консервировани клапанов и сосудов сердца
ATA386679A (de) Verfahren zum herstellen von 3-pyrrolin-2-onen bzw. von pyrrolidin-2-onen, von optisch aktiven isomeren und cis- bzw. trans-isomeren hievon
DE3170699D1 (en) Method for the preparation of transplants with higher biological stability

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee